Article PDF
References
Bona, C.A. Idiotype vaccines: Forgotten but not gone. Nature Med. 4, 668–669 (1998).
Magliani, W. et al. Neonatal mouse immunity against group B streptococcal infection by maternal vaccination with recombinant antiidiotypes. Nature Med. 4, 705–709 (1998).
Ruiz, P.J. et al. Immunity to mutant p53 and tumor rejection induced by idiotypic immunization. Nature Med. 4, 710–712 (1998).
Foon, K.A. et al. Active immunity to the carcinoembryonic antigen in patients treated with an anti-idiotype antibody vaccine. J. Clin. Invest. 96, 334–342 (1995).
Foon, K.A. et al. Immune responses in patients with cutaneous T-cell lymphoma treated with an anti-idiotype antibody mimicking a highly restricted T-cell antigen. Clin. Cancer Res. 1, 1285–1294 (1995).
Foon, K.A. et al. Clinical and immune responses in advanced colorectal cancer patients treated with anti-idiotype monoclonal antibody vaccine that mimics the carcinoembryonic antigen. Clin. Cancer Res. 3, 1267–1276 (1997).
Foon, K.A. et al. Antibody responses in melanoma patients immunized with an anti-idiotype antibody mimicking disialoganglioside GD2. Clin. Cancer Res. 4, 1117–1124 (1998).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Foon, K., Bhattarcharya-Chatterjee, M. Idiotype vaccines in the clinic. Nat Med 4, 870 (1998). https://doi.org/10.1038/nm0898-870a
Issue Date:
DOI: https://doi.org/10.1038/nm0898-870a
This article is cited by
-
Immunotherapy for colorectal cancer
Current Oncology Reports (2001)